Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Blood|September 22, 2020
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19Thomas Hueso, Cécile Pouderoux, Hélène Péré, et al.Ebiomedicine|June 1, 2022
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patientsNicolas Chapuis, Nusaibah Ibrahimi, Thibaut Belmondo, et al.Cell Death & Disease|March 12, 2021
Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkersFrançois-Xavier Danlos, Claudia Grajeda-Iglesias, Sylvère Durand, et al.Journal for Immunotherapy of Cancer|November 30, 2022
Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registriesAlessio Cortellini, Gino M Dettorre, Urania Dafni, et al.Cell|August 19, 2020
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, et al.Therapeutic Advances in Medical Oncology|January 22, 2024
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registryBruno Vincenzi, Alessio Cortellini, Alessandro Mazzocca, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 29, 2023
Previous immune checkpoint inhibitor therapy is associated with decreased COVID-19-related hospitalizations and complications in patients with cancer: Results of a propensity-matched analysis of the OnCovid registryAnahita Mostaghim, Samuel Minkove, Juan Aguilar-Company, et al.Cancer Discovery|February 18, 2022
The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean-Eudes Fahrner, Imran Lahmar, Anne-Gaëlle Goubet, et al.Cell Death and Differentiation|July 7, 2021
Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosisAnne-Gaëlle Goubet, Agathe Dubuisson, Arthur Geraud, et al.Therapeutic Advances in Medical Oncology|November 15, 2021
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registryLaia Garrigós, Cristina Saura, Clara Martinez-Vila, et al.Pageof 3